| Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice A Nai, A Rubio, A Campanella, O Gourbeyre, I Artuso, J Bordini, A Gineste, ... Blood, The Journal of the American Society of Hematology 127 (19), 2327-2336, 2016 | 126 | 2016 |
| Iron induces cell death and strengthens the efficacy of antiandrogen therapy in prostate cancer models J Bordini, F Morisi, AR Elia, P Santambrogio, A Pagani, V Cucchiara, ... Clinical Cancer Research 26 (23), 6387-6398, 2020 | 54 | 2020 |
| Iron causes lipid oxidation and inhibits proteasome function in multiple myeloma cells: a proof of concept for novel combination therapies J Bordini, F Morisi, F Cerruti, P Cascio, C Camaschella, P Ghia, ... Cancers 12 (4), 970, 2020 | 28 | 2020 |
| Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection RM Gittelman, E Lavezzo, TM Snyder, HJ Zahid, CL Carty, R Elyanow, ... JCI insight 7 (10), 2022 | 27 | 2022 |
| Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK* MYC model of multiple myeloma J Bordini, MTS Bertilaccio, M Ponzoni, I Fermo, M Chesi, PL Bergsagel, ... Haematologica 100 (6), 534, 2015 | 25 | 2015 |
| Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma J Bordini, S Galvan, M Ponzoni, MTS Bertilaccio, M Chesi, PL Bergsagel, ... Leukemia 31 (4), 967-970, 2017 | 22 | 2017 |
| CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism M Grioni, A Brevi, E Cattaneo, A Rovida, J Bordini, MTS Bertilaccio, ... Blood advances 5 (14), 2817-2828, 2021 | 20 | 2021 |
| Diagnosis and tracking of SARS-CoV-2 infection by T-cell receptor sequencing RM Gittelman, E Lavezzo, TM Snyder, HJ Zahid, R Elyanow, S Dalai, ... MedRxiv, 2020.11. 09.20228023, 2020 | 19 | 2020 |
| Diagnosis and tracking of past SARS-CoV-2 infection in a large study of Vo’ RM Gittelman, E Lavezzo, TM Snyder, HJ Zahid, R Elyanow, S Dalai, ... Italy through T-cell receptor sequencing. medRxiv 11 (20228023), 10.1101, 2020 | 13 | 2020 |
| PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target FV Sbrana, B Fiordi, J Bordini, D Belloni, F Barbaglio, L Russo, L Scarfò, ... Journal of Cellular and Molecular Medicine 27 (4), 576-586, 2023 | 5 | 2023 |
| Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin‐receptor ligand trap RAP‐536 in β‐thalassemic mice E Tanzi, SM Di Modica, J Bordini, V Olivari, A Pagani, V Furiosi, L Silvestri, ... American Journal of Hematology, 2024 | 3 | 2024 |
| TENT5C/FAM46C modulation in vivo reveals a trade-off between antibody secretion and tumor growth in multiple myeloma M Resnati, S Pennacchio, L Viviani, T Perini, M Materozzi, U Orfanelli, ... Haematologica 109 (6), 1966, 2024 | 1 | 2024 |
| P1489: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA J Bordini, A Morabito, C Taccetti, C Lenzi, P Ranghetti, E Perotta, ... HemaSphere 7 (S3), e6299789, 2023 | 1 | 2023 |
| P597: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY IN CHRONIC LYMPHOCYTIC LEUKEMIA J Bordini, C Lenzi, L Toscani, P Ranghetti, E Perotta, L Scarfò, P Ghia, ... HemaSphere 6, 496-497, 2022 | 1 | 2022 |
| IκBε deficiency accelerates disease development in chronic lymphocytic leukemia J Bordini, C Lenzi, M Frenquelli, A Morabito, A Pseftogas, D Belloni, ... Leukemia 38 (6), 1287-1298, 2024 | | 2024 |
| Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death ME Mantione, M Meloni, I Sana, J Bordini, M Del Nero, M Riba, ... Cell Death & Disease 15 (3), 224, 2024 | | 2024 |
| P1225: CYLD, A NOVEL REGULATOR OF SPLENIC MARGINAL ZONE LYMPHOMA PATHOGENESIS A Pseftogkas, J Bordini, M Frenquelli, F Bonfiglio, M Daibata, ... HemaSphere 7 (S3), e1177106, 2023 | | 2023 |
| Loss of IκBε accelerates disease development in chronic lymphocytic leukemia. J Bordini, Š Pospíšilová, P Ghia | | 2023 |
| Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models J Bordini, F Morisi, AR Elia, P Santambrogio, A Pagani, V Cucchiara, ... CLINICAL CANCER RESEARCH, 2023 | | 2023 |
| P616: THE LOSS OF IΚBΕ INHIBITOR ACCELERATES DISEASE DEVELOPMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA C Lenzi, J Bordini, A Pseftogkas, A Morabito, G Tsiolas, FE Psomopoulos, ... HemaSphere 6, 515-516, 2022 | | 2022 |
